EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Correlation of Serum Chemokine Ligand 14 with Barcelona Clinic Liver Cancer Stage, Lymphocyte Profile, and Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma

Yuan Guo, Hong Tao Hu, Shi Jun Xu, Wei Li Xia, Yan Li, Jun Lu, Xiao Hui Zhao, Yan Zhao, Fang Ting Li, Hai Liang Li

Journal of Vascular and Interventional Radiology · 2023

DOI: 10.1016/j.jvir.2023.01.032 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Vascular and Interventional Radiology, 2023. Verfasst von Yuan Guo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Minimal Invasive Intervention, the Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, People's Repub…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Chemoembolization, Therapeutic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To investigate the clinical relevance of serum chemokine ligand 14 (sCCL14) in patients with hepatocellular carcinoma (HCC) and the effect of transarterial chemoembolization (TACE) on the expression level of sCCL14 and the immune microenvironment. MATERIALS AND METHODS: In this prospective single-center observational study, 52 patients with HCC were recruited from January 2019 to December 2021, their clinical data and blood samples were collected, and the relationship between sCCL14 and progression-free survival (PFS) and TACE treatment response was analyzed. RESULTS: Among the 52 patients with HCC (Barcelona Clinic Liver Cancer [BCLC] Stage A, 25.0%; BCLC Stage B, 44.2%; and BCLC Stage C, 30.8%), patients with BCLC Stage C HCC had significantly lower sCCL14 levels than those of patients with BCLC Stages A and B HCC (P = .001). sCCL14 levels were significantly higher in the first week after treatment than before TACE treatment (P = .024). Baseline sCCL14 levels in patients who showed complete response after TACE treatment were significantly higher than those in other groups, and lower baseline sCCL14 values were associated with shorter PFS times. Multivariate Cox regression analysis showed that sCCL14 level (hazard ratio, 1.855; 95% CI, 1.039-3.311; P = .037) was an independent prognostic factor of PFS. sCCL14 levels negatively correlated with the proportion of B lymphocytes and regulatory T cells in circulating blood and positively correlated with the absolute T-lymphocyte count. CONCLUSIONS: sCCL14 may be a predictive biomarker of TACE effectiveness. Further studies are needed to validate and outline the role of combination immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsChemoembolization, TherapeuticHumansLigandsProspective StudiesNeoplasm StagingLymphocytesRetrospective StudiesTreatment OutcomeTumor Microenvironment

Substanzen

Ligands

Autor:innen und Institutionen

  • Department of Minimal Invasive Intervention, the Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, People's Republic of China.
  • Department of Radiology, the Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, People's Republic of China.
  • Department of Minimal Invasive Intervention, the Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, People's Republic of China; Department of Radiology, the Affiliated Cancer Hospital…

Zitieren

APA

Guo, Y., Hu, H. T., Xu, S. J., Xia, W. L., Li, Y., Lu, J., Zhao, X. H., Zhao, Y., Li, F. T., & Li, H. L. (2023). Correlation of Serum Chemokine Ligand 14 with Barcelona Clinic Liver Cancer Stage, Lymphocyte Profile, and Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology. https://doi.org/10.1016/j.jvir.2023.01.032

Vancouver

Guo Y, Hu HT, Xu SJ, Xia WL, Li Y, Lu J, et al. Correlation of Serum Chemokine Ligand 14 with Barcelona Clinic Liver Cancer Stage, Lymphocyte Profile, and Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology. 2023. doi:10.1016/j.jvir.2023.01.032

BibTeX
@article{Guo2023,
  author = {Guo, Yuan and Hu, Hong Tao and Xu, Shi Jun and Xia, Wei Li and Li, Yan and Lu, Jun and Zhao, Xiao Hui and Zhao, Yan and Li, Fang Ting and Li, Hai Liang},
  title = {Correlation of Serum Chemokine Ligand 14 with Barcelona Clinic Liver Cancer Stage, Lymphocyte Profile, and Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma},
  journal = {Journal of Vascular and Interventional Radiology},
  year = {2023},
  doi = {10.1016/j.jvir.2023.01.032}
}
Kostenlos starten →